- Home
- CIVB vs CLYM Comparison
CIVB vs CLYM Comparison
Compare CIVB & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- CLYM
- Stock Information
- Founded
- CIVB 1884
- CLYM 2018
- Country
- CIVB United States
- CLYM United States
- Employees
- CIVB N/A
- CLYM N/A
- Industry
- CIVB Major Banks
- CLYM
- Sector
- CIVB Finance
- CLYM
- Exchange
- CIVB Nasdaq
- CLYM NYSE
- Market Cap
- CIVB 274.6M
- CLYM 242.8M
- IPO Year
- CIVB N/A
- CLYM 2021
- Fundamental
- Price
- CIVB $22.54
- CLYM $3.00
- Analyst Decision
- CIVB Buy
- CLYM
- Analyst Count
- CIVB 4
- CLYM 0
- Target Price
- CIVB $19.67
- CLYM N/A
- AVG Volume (30 Days)
- CIVB 72.4K
- CLYM 317.4K
- Earning Date
- CIVB 10-29-2024
- CLYM 11-12-2024
- Dividend Yield
- CIVB 2.83%
- CLYM N/A
- EPS Growth
- CIVB N/A
- CLYM N/A
- EPS
- CIVB 2.00
- CLYM N/A
- Revenue
- CIVB $146,565,000.00
- CLYM N/A
- Revenue This Year
- CIVB N/A
- CLYM N/A
- Revenue Next Year
- CIVB $6.04
- CLYM N/A
- P/E Ratio
- CIVB $11.19
- CLYM N/A
- Revenue Growth
- CIVB N/A
- CLYM N/A
- 52 Week Low
- CIVB $13.60
- CLYM $2.35
- 52 Week High
- CIVB $23.70
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- CIVB 69.71
- CLYM N/A
- Support Level
- CIVB $21.78
- CLYM N/A
- Resistance Level
- CIVB $23.01
- CLYM N/A
- Average True Range (ATR)
- CIVB 0.80
- CLYM 0.00
- MACD
- CIVB -0.07
- CLYM 0.00
- Stochastic Oscillator
- CIVB 66.86
- CLYM 0.00
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.